Cargando…

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness

In this paper, high-grade serous ovarian cancer (HGSOC) is studied, which is the most common histological subtype of ovarian cancer. We use a new analytical procedure to combine the bulk RNA-Seq sample for ovarian cancer, mRNA expression-based stemness index (mRNAsi), and single-cell data for ovaria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhihang, Yang, Lili, Huang, Zhenyu, Li, Xuan, Xiao, Juan, Qu, Yinwei, Huang, Lan, Wang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964092/ https://www.ncbi.nlm.nih.gov/pubmed/35360863 http://dx.doi.org/10.3389/fgene.2022.861954

Ejemplares similares

Identification of Potential Prognostic Competing Triplets in High-Grade Serous Ovarian Cancer
por: Zhao, Jian, et al.
Publicado: (2021)

Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma
por: Lv, Xiaofeng, et al.
Publicado: (2023)

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
por: Wang, Huihuan, et al.
Publicado: (2021)

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
por: Kieffer, Yann, et al.
Publicado: (2020)

Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients
por: Jiao, Mi, et al.
Publicado: (2022)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
por: Bound, Nirashaa T., et al.
Publicado: (2022)

Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis
por: Liu, Jinhui, et al.
Publicado: (2019)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Identification of Tumor Microenvironment-Related Prognostic Biomarkers for Ovarian Serous Cancer 3-Year Mortality Using Targeted Maximum Likelihood Estimation: A TCGA Data Mining Study
por: Wang, Lu, et al.
Publicado: (2021)

EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma
por: Chen, Xiao, et al.
Publicado: (2016)

Identification of Biomarkers for Predicting Ovarian Reserve of Primordial Follicle via Transcriptomic Analysis
por: Liu, Li, et al.
Publicado: (2022)

Identification of CD8(+) T Cell Related Biomarkers in Ovarian Cancer
por: Li, Ling, et al.
Publicado: (2022)

Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2023)

Identification of Diagnostic Biomarkers in Systemic Lupus Erythematosus Based on Bioinformatics Analysis and Machine Learning
por: Jiang, Zhihang, et al.
Publicado: (2022)

Integrated weighted gene co‐expression network analysis reveals biomarkers associated with prognosis of high‐grade serous ovarian cancer
por: Wang, Bo, et al.
Publicado: (2022)

Identification of a Gene Signature of Cancer-Associated Fibroblasts to Predict Prognosis in Ovarian Cancer
por: Zeng, Li, et al.
Publicado: (2022)

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
por: Azzalini, Eros, et al.
Publicado: (2022)

Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2021)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
por: Newtson, Andreea, et al.
Publicado: (2021)

Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
por: Zhang, Yongjian, et al.
Publicado: (2022)

Identification of metastasis and prognosis-associated genes for serous ovarian cancer
por: Yang, Yijun, et al.
Publicado: (2020)

A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer
por: Zhan, Feng, et al.
Publicado: (2023)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer
por: Dutt, Mriga, et al.
Publicado: (2023)

Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer
por: Si, Manfei, et al.
Publicado: (2019)

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma
por: He, Yunan, et al.
Publicado: (2020)

Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer
por: Xiang, Li, et al.
Publicado: (2018)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Identification of Biomarkers Related to Prognosis of Bladder Transitional Cell Carcinoma
por: Liu, Zhihua, et al.
Publicado: (2021)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
por: Jiang, Linlin, et al.
Publicado: (2022)

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
por: Dai, Danian, et al.
Publicado: (2021)

Digital Pathology-based Study of Cell- and Tissue-level Morphologic Features in Serous Borderline Ovarian Tumor and High-grade Serous Ovarian Cancer
por: Jiang, Jun, et al.
Publicado: (2021)

Identification and verification of m7G-Related genes as biomarkers for prognosis of sarcoma
por: Qin, Haotian, et al.
Publicado: (2023)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Song, Dingli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ld3n4atc2l23f31hv8bgj1q1al